Home3D Tumour Intelligence
3D RESEARCH OPERATIONS
3D Tumour Intelligence
Manage tumour-model studies, imaging, quantitative response analysis, scientific review, and controlled learning.
Active Studies18Across research models
In Imaging6Acquisition active
Under Review4Scientist attention
Approved Results32Scientific sign-off
Training-Eligible14Separate governance review
Featured Active Study
Current response analysis
BC-001 · OGC-2401
Breast Cancer Spheroid Response Study
Breast Cancer · TNBC, HER2-
Response AnalysisModel3D Tumour SpheroidLeadDr. S. MokoenaTimepointsDay 0 · Day 3 · Day 7TreatmentsControl · Drug A · Drug B
Latest response · Drug BStrong Response
Tumour size-71%
Viability18%
Open 3D Tumour & MRI View AnalysisStudy Pipeline
From setup to approved result
01Setup4
02Samples3
03Treatment5
04Imaging6
05Segmentation & QC4
06Response Analysis3
07Scientific Review4
08Approved Result32
Study Registry
6 visible studies · select a row to open workspace
| Study ID | Asset | Study Name | Cancer Model | Model Type | Treatments | Timepoints | Stage | QC | 3D Model | Lead Scientist | Last Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BC-001 | OGC-2401 | Breast Cancer Spheroid Response Study | Breast CancerTNBC, HER2- | Spheroid | Control · Drug A · Drug B | Day 0 · Day 3 · Day 7 | Response Analysis | Passed | 3D View | Dr. S. Mokoena | 2026-10-03 |
| BC-002 | OGC-BC-118 | Dose Response Validation | Breast CancerHR+ / HER2+ | Spheroid | Control · Low Dose · High Dose | Day 0 · Day 3 · Day 7 | Treatment | Pending | 3D View | Dr. J. Patel | 2026-10-02 |
| GBM-004 | OGC-NS-321 | Glioblastoma Penetration Study | GlioblastomaIDH-wildtype | Organoid | Control · Drug A · Drug B | Day 0 · Day 3 · Day 7 | Imaging | Needs Review | 3D View | Dr. M. Rossi | 2026-10-01 |
| LU-003 | OGC-LU-104 | NSCLC PROTAC Response Study | Lung CancerNSCLC | Spheroid | Control · Drug A · Drug B | Day 0 · Day 3 · Day 7 | QC Review | Needs Review | 3D View | Dr. A. Kumar | 2026-09-30 |
| OV-006 | OGC-OV-207 | Ovarian Signature Validation | Ovarian CancerHigh-grade serous | Organoid | Control · Drug A · Drug B | Day 0 · Day 3 · Day 7 | Scientific Review | Passed | 3D View | Dr. L. Chen | 2026-09-27 |
| PA-002 | OGC-PA-084 | PDAC Stromal Response Study | Pancreatic CancerPDAC | Spheroid | Control · Drug A · Drug B | Day 0 · Day 3 · Day 7 | Approved | Passed | 3D View | Dr. S. Mokoena | 2026-09-26 |
Recent Imaging
Acquisitions pending or through QC
Review Queue
Scientist attention and sign-off required